Mu-opioid receptor activation promotes in vitro and in vivo tumor growth in head and neck squamous cell carcinoma - ScienceDirect
Opioids in cancer: The κ‑opioid receptor (Review)
The impact of opioid receptor heterodimerization on opioid receptor... | Download Scientific Diagram
Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New Indications | Pharmacological Reviews
Cells | Free Full-Text | Role of NRF2 in Lung Cancer | HTML
Frontiers | Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management
Hot topics in opioid pharmacology: mixed and biased opioids - British Journal of Anaesthesia
Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text
Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns | Journal of Chemical Information and Modeling
Nanobody-enabled monitoring of kappa opioid receptor states | Nature Communications
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences
Opioid receptor - Wikipedia
The relationship between the level of μ-opioid receptor (μORs) and postoperative analgesic use in patients undergoing septoplasty: a prospective randomized controlled trial | BMC Anesthesiology | Full Text
Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction? | SpringerLink
Sotorasib for Lung Cancers with KRAS p.G12C Mutation | NEJM
Frontiers | Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain - The Journal of Pain
Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells | British Journal of Cancer
PDB-101: undefined
Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design | Scientific Reports
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Frontiers | Opioid Receptors in Immune and Glial Cells—Implications for Pain Control
Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells | British Journal of Cancer